Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index falling 2.1% and the Health Care Select Sector SPDR Fund (XLV) dropping 2.8%.
The iShares Biotechnology ETF (IBB) slumped 6%.
In corporate news, Beam Therapeutics (BEAM) shares tumbled past 17% after it reported a wider Q1 loss compared with a year earlier.
Philips (PHG) shares fell 5.5% after it reported flat Q1 adjusted earnings per share, while sales declined.
Viridian Therapeutics (VRDN) shares were down 7.4% after it reported a Q1 net loss of $0.87 per diluted share, widening from a loss of $0.59 a year earlier.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。